Boston Common Asset Management, LLC Haleon PLC Transaction History

Boston Common Asset Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 11, 2023	SELL	$7.85 - $8.94 $105,033 - $119,617	-13,380 Reduced 20.86%	50,750 $423,000
Q2 2023 Jul 24, 2023	SELL	$8.04 - $9.0 $1,045 - $1,170	-130 Reduced 0.2%	64,130 $537,000
Q4 2022 Jan 26, 2023	SELL	$5.96 - $8.06 $739 - $999	-124 Reduced 0.19%	64,260 $514,000
Q3 2022 Oct 20, 2022	BUY	$5.63 - $7.5 $362,481 - $482,880	64,384 New	64,384 $392,000

639

412M

149K

16K

Ticker HLN
Exchange
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 4,617,290,240
Market Cap $44.8B
Description
Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...

Get notified when there are updates to the investment portfolio of Boston Common Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boston Common Asset Management, LLC with notifications on news.